Page last updated: 2024-10-17

phloroglucinol and Cancer of Lung

phloroglucinol has been researched along with Cancer of Lung in 5 studies

Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.

Research Excerpts

ExcerptRelevanceReference
"The microbial polyketide, 2, 4-diacetylphloroglucinol (DAPG), exhibited a broad-spectrum of anti-leukemic, anti-lung, and anti-breast cancer properties."7.83Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins. ( Kennedy, K; Krishna, R; Lakshmi, P; Sakthivel, N; Veena, VK, 2016)
"Treatment with phloroglucinol effectively inhibited mesenchymal phenotypes of basal type breast cancer cells through downregulation of SLUG without causing a cytotoxic effect."5.42Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition. ( Cui, YH; Hwang, E; Kang, JS; Kim, HJ; Kim, MJ; Kim, RK; Lee, SJ; Lee, YY; Suh, Y; Yoo, KC, 2015)
"The microbial polyketide, 2, 4-diacetylphloroglucinol (DAPG), exhibited a broad-spectrum of anti-leukemic, anti-lung, and anti-breast cancer properties."3.83Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins. ( Kennedy, K; Krishna, R; Lakshmi, P; Sakthivel, N; Veena, VK, 2016)
"Treatment with phloroglucinol effectively inhibited mesenchymal phenotypes of basal type breast cancer cells through downregulation of SLUG without causing a cytotoxic effect."1.42Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition. ( Cui, YH; Hwang, E; Kang, JS; Kim, HJ; Kim, MJ; Kim, RK; Lee, SJ; Lee, YY; Suh, Y; Yoo, KC, 2015)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, WT1
Chen, YK1
Lin, SS1
Hsu, FT1
Kim, RK1
Suh, Y1
Yoo, KC1
Cui, YH1
Hwang, E1
Kim, HJ1
Kang, JS1
Kim, MJ1
Lee, YY1
Lee, SJ1
Veena, VK1
Kennedy, K1
Lakshmi, P1
Krishna, R1
Sakthivel, N1
Donà, M1
Dell'Aica, I1
Pezzato, E1
Sartor, L1
Calabrese, F1
Della Barbera, M1
Donella-Deana, A1
Appendino, G1
Borsarini, A1
Caniato, R1
Garbisa, S1
Takasaki, M1
Konoshima, T1
Etoh, H1
Pal Singh, I1
Tokuda, H1
Nishino, H1

Other Studies

5 other studies available for phloroglucinol and Cancer of Lung

ArticleYear
Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
    Anticancer research, 2018, Volume: 38, Issue:4

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Mov

2018
Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition.
    Cancer science, 2015, Volume: 106, Issue:1

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Epithelial-Mesenchymal Transition;

2015
Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins.
    Molecular and cellular biochemistry, 2016, Volume: 414, Issue:1-2

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Humans; Leukemia; Lung Neoplasms; Molecul

2016
Hyperforin inhibits cancer invasion and metastasis.
    Cancer research, 2004, Sep-01, Volume: 64, Issue:17

    Topics: Adenocarcinoma; Animals; Apoptosis; Bridged Bicyclo Compounds; Cell Division; Cell Survival; Colonic

2004
Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis.
    Cancer letters, 2000, Jul-03, Volume: 155, Issue:1

    Topics: 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antivi

2000